NEW YORK, Dec. 24, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of ... 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per ...
Read here for a detailed financial analysis of Medifast stock post-pandemic, GLP-1 impact, and the company's collaboration ...
Shares of LifeMD, Inc. (NASDAQ:LFMD – Get Free Report) have received an average recommendation of “Moderate Buy” from the seven analysts that are presently covering the stock, MarketBeat.com reports.
15.97% of the stock is owned by company insiders. A number of institutional investors and hedge funds have recently bought and sold shares of LFMD. Bank of New York Mellon Corp lifted its stake in ...
Justin Schreiber, the Chief Executive Officer of $LFMD ($LFMD), sold 25,000 shares of the company on 01-02-2025. We received data on the trade from a recent SEC ...
corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of LFMD in relation to earlier this year.
More about LifeMD YTD Price Performance:-38.24% Average Trading Volume: 637,945 Technical Sentiment Consensus Rating: Hold Current Market Cap: $221.8M Find detailed analytics on LFMD stock on ...
NEW YORK, Dec. 24, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of ... 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per ...
all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter LifeMD ( (LFMD)) has shared an announcement. LifeMD announced ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.